12/23/2024
3:39 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:16 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
5:04 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:18 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:19 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:41 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
4:06 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
3:53 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:44 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:15 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
7:34 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
11/14/2024
8:38 AM | Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G | |
10/16/2024
8:15 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
07/03/2024
4:27 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
1:39 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
6:06 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:00 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2024
4:54 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:30 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:57 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024
11:57 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
3:14 PM | Arrowhead Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024
5:32 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:22 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
First JFK… next Elon? (Ad) Today, I have another controversial prediction.
One which I will take no pleasure in seeing come true.
See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:48 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:38 PM | Arrowhead Pharmaceuticals (Subject)
Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:22 PM | Arrowhead Pharmaceuticals (Subject)
Ferrari Mauro (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:17 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:58 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:02 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:33 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
4:14 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:39 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:21 PM | Arrowhead Pharmaceuticals (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:08 PM | Arrowhead Pharmaceuticals (Subject)
Oliver Tracie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
12:49 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:06 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:25 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
11:24 AM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:44 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
